Heilongjiang Weikang

Heilongjiang Weikang Pharmaceutical is a Chinese pharmaceutical company headquartered in Harbin, specializing in the development and manufacturing of modern and traditional Chinese medicines. The company is particularly recognized for its expertise in injectable formulations, including high-volume and small-volume injections derived from natural plant extracts. Its flagship products, such as Ginkgo Biloba Extract Injection, target cardiovascular and cerebrovascular diseases, while other offerings address respiratory and inflammatory conditions. Weikang operates multiple GMP-certified production facilities and maintains a robust distribution network across China. The firm integrates traditional herbal knowledge with modern pharmacological standards to serve the domestic healthcare market.